Trial
NCT01796522
Utility of Tocolytic Therapy for Maintenance Tocolysis in the Management of Threatened Preterm Delivery
Phase IIIWITHDRAWNEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Instituto de Investigacion Sanitaria La Fe
Collaborators
—
Condition
Preterm Delivery.
Intervention
progesterone 200 mg / day vaginally
Why stopped
have been published new studies that it showed the ineffectiveness of the treatments proposed in this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-07-22